MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

G-5555

CAS No. : 1648863-90-4

MCE 国际站：G-5555

产品活性：G-5555 是有效 PAK1 抑制剂，对 PAK1 和 PAK2 的 K_i 值分别为 3.7 nM 和 11 nM。

研究领域：Cell Cycle/DNA Damage | Cytoskeleton

作用靶点：PAK

In Vitro: G-5555 is a potent PAK1 inhibitor with a K_i of 3.7 nM. G-5555 shows excellent kinase selectivity and inhibits only eight out of the 235 kinases tested other than PAK1 with inhibition >70%: PAK2, PAK3, KHS1, Lck, MST3, MST4, SIK2, and YSK1. The IC₅₀s of G-5555 against SIK2, PAK2, KHS1, MST4, YSK1, MST3 and Lck are 9, 11, 10, 20, 34, 43, 52 nM, respectively. In general, G-5555 demonstrates high selectivity for the group I PAKs. There is negligible activity for G-5555 against the hERG channel with IC₅₀ more than 10 µM in a patch clamp assay. G-5555 potently inhibits PAK2, with a K_i of 11 nM. In an array of 23 breast cancer cell lines, G-5555 has significantly greater growth inhibitory activity in cell lines that are PAK-amplified compared to non-amplified lines.

In Vivo: G-5555 exhibits low blood clearance and an acceptable half-life. Good oral exposure (AUC = 30 µM•h) and high oral bioavailability (F = 80%) are achieved. In an H292 non-small cell lunger cancer (NSCLC) xenograft study in mice, G-5555 inhibits phosphorylation of the PAK1/2 downstream substrate mitogen-activated protein kinase 1 (MEK1) S298 and, when administered at an oral dose of 25 mg/kg b.i.d., imparts 60% tumor growth inhibition in this model13 and a PAK1 amplified breast cancer xenograft model, MDAMB-175.

相关产品：Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Kinase Inhibitor Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Cytoskeleton Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Fingolimod hydrochloride | IPA-3 | 5-Aminosalicylic Acid | FRAX597 | FRAX486 | NVS-PAK1-1 | GNE 2861 | FRAX1036 | LCH⁻⁷749944 | G-5555 hydrochloride | Mesalamine impurity P | NVS-PAK1-C

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。